Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001387131-22-003640
Filing Date
2022-03-14
Accepted
2022-03-14 17:12:43
Documents
85
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tnxp-10k_123121.htm   iXBRL 10-K 3201874
2 DESCRIPTION OF REGISTRANT'S SECURITIES ex4-06.htm EX-4.06 26471
3 LIST OF SUBSIDIARIES ex21-01.htm EX-21.01 8491
4 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ex23-01.htm EX-23.01 4935
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 17984
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 9685
7 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER ex32-01.htm EX-32.01 8048
  Complete submission text file 0001387131-22-003640.txt   8632527

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE tnxp-20211231.xsd EX-101.SCH 70705
9 XBRL CALCULATION FILE tnxp-20211231_cal.xml EX-101.CAL 67836
10 XBRL DEFINITION FILE tnxp-20211231_def.xml EX-101.DEF 259962
11 XBRL LABEL FILE tnxp-20211231_lab.xml EX-101.LAB 473904
12 XBRL PRESENTATION FILE tnxp-20211231_pre.xml EX-101.PRE 366354
79 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-10k_123121_htm.xml XML 838026
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36019 | Film No.: 22737519
SIC: 2834 Pharmaceutical Preparations